Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(9%)
Results Posted
13%(1 trials)

Phase Distribution

Ph not_applicable
3
27%
Ph phase_3
2
18%
Ph phase_4
2
18%
Ph phase_2
2
18%
Ph phase_1
2
18%

Phase Distribution

2

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
2(18.2%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
2(18.2%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
3(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(8)
Other(1)

Detailed Status

Completed8
unknown1
Recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (18.2%)
Phase 22 (18.2%)
Phase 32 (18.2%)
Phase 42 (18.2%)
N/A3 (27.3%)

Trials by Status

unknown19%
completed873%
recruiting19%
enrolling_by_invitation19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11